How many subsidiaries does Cronos Group Inc. file with the SEC?

9, listed in its most recent exhibit 21. They are incorporated across 3 jurisdictions (Canada, Israel, Netherlands). That exhibit is filed with the company's annual report and is the company's own list, not an estimate.

Is Cronos Group Inc. financially healthy?

Cronos Group Inc. scores 6 out of 8 on the Piotroski F-score. Only 8 of the nine tests could be computed from what it filed; the rest need a prior year it has not reported. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.

Who are the largest institutional holders of Cronos Group Inc.?

Among the managers tracked here, the biggest positions as of the 2026-Q2 13F filings are RENAISSANCE TECHNOLOGIES LLC (trimming), CITADEL ADVISORS LLC (adding), GEODE CAPITAL MANAGEMENT, LLC (adding). Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.

Cronos Group Inc. (CRON)

Nasdaq · Common Stock · Medicinal Chemicals & Botanical Products

One email a week from me: what it filed, which 13F holders added or cut, where its scores stand. Free.

Corporate structure

9 entities across 3 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-02-26 — see the exhibit.

Which other public companies file entities in the same places:

Israel5 Canada3 Netherlands1

Subsidiaries of Cronos Group Inc. as disclosed in its SEC filing
Entity	Jurisdiction	Note
Cronos Growing Company Inc.	Canada
Hortican Inc.	Canada
Peace Naturals Project Inc.	Canada
Cronos Research Labs Ltd.	Israel
Cronos Israel G.S. Store Ltd.	Israel
Cronos Israel G.S. Cultivation Ltd.	Israel
Cronos Israel G.S. Pharmacy Ltd.	Israel
Cronos Israel G.S. Manufacturing Ltd.	Israel
CGM B.V.	Netherlands

Financial health

Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.

Piotroski F-score

6 / 8

FAILReturn on assets positiveROA -0.8%
PASSOperating cash flow positiveOCF 26M
FAILReturn on assets improving3.5% → -0.8%
PASSCash flow exceeds earningsOCF 26M vs NI -9M
FAILLong-term debt ratio fallingno debt reported
PASSCurrent ratio improving18.84 → 19.59
PASSNo share dilution386M → 383M shares
PASSGross margin improving21.4% → 42.8%
PASSAsset turnover improving0.10× → 0.12×

Six-year record

Year	Revenue	Net income	Free cash flow	Gross margin	Shares
FY2020	$46.7M	−$73.1M	−$173.9M	-55.3%	351,576,848
FY2021	$74.4M	−$396.1M	−$164.8M	-23.6%	370,390,965
FY2022	$91.9M	−$168.7M	−$92.4M	13.0%	376,961,797
FY2023	$87.2M	−$74.0M	−$45.3M	13.7%	380,964,739
FY2024	$117.6M	$41.1M	$6.4M	21.4%	385,557,002
FY2025	$146.6M	−$9.4M	$149,000	42.8%	383,468,522

Ownership flow

7 institutions tracked — 4 added, 1 reduced.

Institutional holders of Cronos Group Inc. and their share-count change
Manager	Kind	Shares	Change	Value
CITADEL ADVISORS LLC	Hedge fund	1,278,285	+422,628	$3.6M
RENAISSANCE TECHNOLOGIES LLC	Hedge fund	1,742,149	−267,400	$4.8M
MORGAN STANLEY	Active fund	304,527	+54,132	$846,586
BANK OF AMERICA CORP /DE/	Active fund	157,631	+41,814	$438,214
GEODE CAPITAL MANAGEMENT, LLC	Index	577,274	+25,638	$1.6M

From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.

Capital returned

What the company actually paid out and bought back, as reported — the record behind any yield figure.

Shares repurchased

2026Q1: $16.7M
2025Q1: $0

Identity

CIK: 0001656472
LEI: 549300CWB04E8UOTWX71
FIGI: BBG00D1PMS80
SIC: 2833 · Medicinal Chemicals & Botanical Products
Incorporated: British Columbia, Canada
Headquarters: STAYNER, Ontario, Canada

Ownership

Institutional: 15.5%
Institutions: 239
Insiders: 49.1%

Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.

Other medicinal chemicals & botanical products companies

Cronos Group Inc. files under SIC 2833 — all 8 medicinal chemicals & botanical products companies compared on assets and F-score.

Trulieve Cannabis Corp.TRLV Canopy Growth CorpCGC Ascend Wellness Holdings, Inc.AAWH USANA HEALTH SCIENCES INCUSNA Jushi Holdings Inc.JUSH Niagen Bioscience, Inc.NAGE

Dealer positioning — end of day

Where dealer gamma sat in CRON’s option chain after the close on 2026-09-01, aggregated from the full chain. This is a once-a-day snapshot, not a live read — 50 contracts.

Net gamma (per 1% move): $287,063.947
Gamma flip: 2.50
Call wall: 3
Put wall: 2
Spot at capture: 3.37

Computed from the listed option chain by my own aggregation, once, after the close — it describes where positioning sat that evening and does not update through the next session. The version that rebuilds per strike while the market is open is the intraday gamma product. Not investment advice.

Questions about Cronos Group Inc.

How many subsidiaries does Cronos Group Inc. file with the SEC?: 9, listed in its most recent exhibit 21. They are incorporated across 3 jurisdictions (Canada, Israel, Netherlands). That exhibit is filed with the company's annual report and is the company's own list, not an estimate.
Is Cronos Group Inc. financially healthy?: Cronos Group Inc. scores 6 out of 8 on the Piotroski F-score. Only 8 of the nine tests could be computed from what it filed; the rest need a prior year it has not reported. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.
Who are the largest institutional holders of Cronos Group Inc.?: Among the managers tracked here, the biggest positions as of the 2026-Q2 13F filings are RENAISSANCE TECHNOLOGIES LLC (trimming), CITADEL ADVISORS LLC (adding), GEODE CAPITAL MANAGEMENT, LLC (adding). Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.

This page is one panel of the terminal

The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.

Download the terminal See pricing

Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.